Dengue prevention: New Tools and Persistent Challenges
Dr. Gabriela Paz-Bailey is Chief of the Dengue Branch at the Division of Vector-Borne Diseases of the Centers for Disease Control and Prevention (CDC), San Juan, Puerto Rico. In this role, she oversees research, surveillance, and evaluation of interventions aimed at reducing the burden of arboviral diseases. Her work focuses on translating scientific evidence into public health action, with an emphasis on interventions that can be implemented at scale and sustained over time.
Welcome to Vaccines Beat 19th issue
In our “Coffee with the Expert” section, we had the pleasure of featuring Dr. Gabriela Paz-Bailey, MD, PhD, MSc, DTM&H, Head of the Dengue...
Highlights Issue 019
A summary of the latest News & Alerts in the fields of vaccinology, vaccines, vaccination, and vaccine-preventable diseases. We curate the latest information on regulatory updates, emerging trends, breakthroughs in vaccine technology, vaccine safety and efficacy, global immunization developments and outbreak alerts, as a resource to keep our community informed.
Latest published papers and commentaries from the chief editors – 019
Latest impactful scientific publications that stand out for their potential bearing on healthcare. We introduce groundbreaking research findings, innovative treatment modalities, results from phase 1 to 3 vaccine clinical trials, or paradigm-shifting discoveries that redefine our understanding of infectious diseases and therapeutic approaches for all vaccine-preventable diseases.
COVID-19 Vaccines: Debunking Myths, Understanding Risks, and Reinforcing the Reality of Protection
Introduction Between 2020 and 2024, global COVID-19 vaccination efforts are estimated to have averted 2.5 million deaths (range, 1.4–4.0 million) and saved 15 million life-years...
The importance to vaccinate against rotavirus, hepatitis A, hepatitis B, respiratory syncytial virus, and...
The recent updates issued by the U.S. Centers for Disease Control and Prevention (CDC) on routine childhood immunization underscore the importance of evidence-based guidance...
How new vaccines are developed
The U.S. Food and Drug Administration’s (FDA’s) Center for Biologics Evaluation and Research (CBER) is responsible for regulating vaccine use in the United States. The general stages...
Nutritional status and immune response to vaccines
The interaction between nutritional status and systemic immune response has been established for decades. Optimal nutritional status is associated with a better immune response, while conditions that compromise nutritional health contribute to a higher risk of infectious diseases, their clinical course, and prognosis.




























